These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 29476608)

  • 21. Pilot Study of the Performance of 19-G Needle in Endobronchial Ultrasound-guided Transbronchial Aspiration for the Diagnosis and Testing of Molecular Markers in Lung Cancer.
    Wahidi MM; Davidson K; Shofer S; Mahmood K; Cheng G; Giovacchini C; Jones C; Jug R; Pavlisko EN; Wang X; Gu L; Weimholt C; Zhou Z; Chen A
    J Bronchology Interv Pulmonol; 2021 Jul; 28(3):209-214. PubMed ID: 33273249
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of lung cancer biomarkers profile for the decision of targeted therapy in EBUS-TBNA cytological samples.
    Gürün Kaya A; Çiledağ A; Erol S; Öz M; Doğan Mülazımoğlu D; Işık Ö; Özakıncı H; Çiftçi F; Şen E; Ceyhan K; Kaya A; Karnak D; Çelik G; İsmail S
    Scott Med J; 2022 Feb; 67(1):18-27. PubMed ID: 35147461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Feasibility of EBUS-TBNA for histopathological and molecular diagnostics of NSCLC-A retrospective single-center experience.
    Karadzovska-Kotevska M; Brunnström H; Kosieradzki J; Ek L; Estberg C; Staaf J; Barath S; Planck M
    PLoS One; 2022; 17(2):e0263342. PubMed ID: 35108331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed?
    Yarmus L; Akulian J; Gilbert C; Feller-Kopman D; Lee HJ; Zarogoulidis P; Lechtzin N; Ali SZ; Sathiyamoorthy V
    Ann Am Thorac Soc; 2013 Dec; 10(6):636-43. PubMed ID: 24079724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suitability of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration versus Paired Transbronchial Biopsy Specimens for Evaluating Programmed Death Ligand-1 Expression in Stage III and IV Lung Cancer: A Comparative Retrospective Study.
    Matsuoka H; Araya T; Kita T; Terada N; Yamamura K; Nishikawa S; Tambo Y; Sone T; Kimura H; Ooi A; Kasashima S; Kawashima A; Kasahara K
    J Cancer; 2021; 12(15):4478-4487. PubMed ID: 34149911
    [No Abstract]   [Full Text] [Related]  

  • 26. Feasibility of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Cytology Specimens for Next Generation Sequencing in Non-small-cell Lung Cancer.
    Stoy SP; Segal JP; Mueller J; Furtado LV; Vokes EE; Patel JD; Murgu S
    Clin Lung Cancer; 2018 May; 19(3):230-238.e2. PubMed ID: 29277564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adequacy of Samples Obtained by Endobronchial Ultrasound with Transbronchial Needle Aspiration for Molecular Analysis in Patients with Non-Small Cell Lung Cancer. Systematic Review and Meta-Analysis.
    Labarca G; Folch E; Jantz M; Mehta HJ; Majid A; Fernandez-Bussy S
    Ann Am Thorac Soc; 2018 Oct; 15(10):1205-1216. PubMed ID: 30011388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Handling and standardization of EBUS needle aspiration in NSCLC patients: The value of the cell block, a monoinstitutional experience.
    Parente P; Carbonelli C; Biancofiore G; Sukthi A; Di Micco CM; Vairo M; Fuso P; Taurchini M; Graziano P
    Thorac Cancer; 2022 Sep; 13(17):2480-2488. PubMed ID: 35868633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
    Esterbrook G; Anathhanam S; Plant PK
    Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-World Outcomes of Patients With Advanced Non-small Cell Lung Cancer Treated With Anti-PD1 Therapy on the Basis of PD-L1 Results in EBUS-TBNA vs Histological Specimens.
    Tajarernmuang P; Ofiara L; Beaudoin S; Wang H; Benedetti A; Gonzalez AV
    Chest; 2021 Aug; 160(2):743-753. PubMed ID: 33675792
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adequacy of small biopsy and cytology specimens for comprehensive genomic profiling of patients with non-small-cell lung cancer to determine eligibility for immune checkpoint inhibitor and targeted therapy.
    Faber E; Grosu H; Sabir S; San Lucas FA; Barkoh BA; Bassett RL; Luthra R; Stewart J; Roy-Chowdhuri S
    J Clin Pathol; 2022 Sep; 75(9):612-619. PubMed ID: 33952592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.
    Cicek T; Ozturk A; Yılmaz A; Aktas Z; Demirag F; Akyurek N
    Clin Respir J; 2019 Feb; 13(2):92-97. PubMed ID: 30582673
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prospective, Randomized Trial for the Comparison of 19-G and 22-G Endobronchial Ultrasound-Guided Transbronchial Aspiration Needles; Introducing a Novel End Point of Sample Weight Corrected for Blood Content.
    Wolters C; Darwiche K; Franzen D; Hager T; Bode-Lesnievska B; Kneuertz PJ; He K; Koenig M; Freitag L; Wei L; Eisenmann S; Taube C; Weinreich G; Oezkan F
    Clin Lung Cancer; 2019 May; 20(3):e265-e273. PubMed ID: 30914312
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Performance of Ventana SP263 PD-L1 assay in endobronchial ultrasound guided-fine-needle aspiration derived non-small-cell lung carcinoma samples.
    Chauhan A; Siegel L; Freese R; Racila E; Stewart J; Amin K
    Diagn Cytopathol; 2021 Mar; 49(3):355-362. PubMed ID: 33142053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Programmed death ligand 1 expression in EBUS aspirates of non-small cell lung cancer: Is interpretation affected by type of fixation?
    Gosney JR; Haragan A; Chadwick C; Giles TE; Grundy S; Tippett V; Gumparthy KP; Wight A; Tan HG
    Cancer Cytopathol; 2020 Feb; 128(2):100-106. PubMed ID: 31851430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between endobronchial ultrasound-guided (EBUS)-transbronchial needle aspiration utility and computed tomography staging, node size at EBUS, and positron emission tomography scan node standard uptake values: A retrospective analysis.
    Marchand C; Medford ARL
    Thorac Cancer; 2017 Jul; 8(4):285-290. PubMed ID: 28436173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility and reliability of evaluate PD-L1 expression determination using small biopsy specimens in non-small cell lung cancer.
    Chen M; Xu Y; Zhao J; Li J; Liu X; Zhong W; Wang M
    Thorac Cancer; 2021 Sep; 12(17):2339-2344. PubMed ID: 34291566
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Testing for Targeted Therapy in Advanced Non-Small Cell Lung Cancer: Suitability of Endobronchial Ultrasound Transbronchial Needle Aspiration.
    Casadio C; Guarize J; Donghi S; Di Tonno C; Fumagalli C; Vacirca D; Dell'Orto P; De Marinis F; Spaggiari L; Viale G; Barberis M
    Am J Clin Pathol; 2015 Oct; 144(4):629-34. PubMed ID: 26386084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adequacy of cytology and small biopsy samples obtained with rapid onsite evaluation (ROSE) for predictive biomarker testing in non-small cell lung cancer.
    Hendry S; Mamotte L; Mesbah Ardakani N; Leslie C; Tesfai Y; Grieu-Iacopetta F; Izaac K; Singh S; Ardakani R; Thomas M; Giardina T; Robinson C; Frost F; Amanuel B
    Pathology; 2023 Dec; 55(7):917-921. PubMed ID: 37805343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PD-L1 testing on the EBUS-FNA cytology specimens of non-small cell lung cancer.
    Wang G; Ionescu DN; Lee CH; Hiruki T; Myers R; Shaipanich T; Lam S; Melosky B; Zhou C
    Lung Cancer; 2019 Oct; 136():1-5. PubMed ID: 31421256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.